MTOR and urinary bladder cancer: LncUCA1 activates mTOR, by inducing signal transducer and activator of transcription 3 protein, and inhibiting miR-143, thereby upregulating hexokinase 2 and glycolysis in bladder cancer (Li et al., 2014).